In March 2025, the company announced new strategies for a direct-to-client supplying of its Wegovy weight loss drug. The company set up a whole new pharmacy, referred to as NovoCare, which would charge customers $499 a month for entry to the drug, under 50 percent the price of the drug by other pharmaceutical distribution networks.[fifty three]are … Read More